Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Mar 31, 2019

Filed with the SEC on May 10, 2019 and accepted by EDGAR at May 10, 2019, 21:14 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2019-01-01 to 2019-03-31$436.3kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2018-10-01 to 2019-03-31$645.5kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2019-01-01 to 2019-03-31−$1.5mus-gaap:OperatingIncomeLoss
Operating income6 months2018-10-01 to 2019-03-31−$2.6mus-gaap:OperatingIncomeLoss
Net income3 months2019-01-01 to 2019-03-31−$2.2mus-gaap:NetIncomeLoss
Net income6 months2018-10-01 to 2019-03-31−$3.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-01-01 to 2019-03-31−$0.20us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2018-10-01 to 2019-03-31−$0.34us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2018-10-01 to 2019-03-31−$2.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2019-03-31$2.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-03-31$2.4mus-gaap:AssetsCurrent
Total assetsAt period end2019-03-31$2.6mus-gaap:Assets
Current liabilitiesAt period end2019-03-31$2.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-03-31$2.1mus-gaap:Liabilities
Shareholders' equityAt period end2019-03-31$444.6kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-19-008306. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.